Page last updated: 2024-11-03

riluzole and Methemoglobinemia

riluzole has been researched along with Methemoglobinemia in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woolf, A1
Carstairs, SD1
Tanen, DA1
Viallon, A1
Page, Y1
Bertrand, JC1

Other Studies

2 other studies available for riluzole and Methemoglobinemia

ArticleYear
Riluzole-induced methemoglobinemia.
    Annals of emergency medicine, 2004, Volume: 43, Issue:2

    Topics: Adult; Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Female; Hematologic Tests;

2004
Methemoglobinemia due to riluzole.
    The New England journal of medicine, 2000, Aug-31, Volume: 343, Issue:9

    Topics: Adult; Amyotrophic Lateral Sclerosis; Drug Overdose; Excitatory Amino Acid Antagonists; Female; Huma

2000